ST-BRUNO, QC, May 4 /CNW Telbec/ - While seeing their baby smile is a guaranteed way of brightening any new parent's day, the process of cutting 20 new pearly whites can be distressing for babies - and parents. A recent Angus Reid survey, conducted on behalf of Boiron Canada, reveals 74 per cent of parents with children between the ages of six months and five years report teething pain as the most prevalent condition affecting their young children, topping other common childhood conditions like diaper rash and earaches.
"Teething is something that every child goes through, and it can often be a difficult time for both the child and parents," said Nicole Chamard, pharmacist. "Understanding that teething can cause a wide variety of symptoms can help parents find effective ways for treating their child's specific concerns."
Teething symptoms can occur weeks before the tooth rises, and can often be a challenge for parents to manage. Survey results show that when it comes to treating teething symptoms, 33 per cent of respondents claimed that irritability was the most difficult aspect of teething to manage. Ranking close behind were pain (25 per cent), sleeplessness (19 per cent) and drooling (11 per cent).
To help their children overcome the discomfort of teething, almost three-quarters (72 per cent) of respondents reported using some form of medicine to relieve their child's teething symptoms. In selecting medicine for their children, 98 per cent of parents reported efficacy as the most important product attribute for consideration, followed by safety (95 per cent) and ease of administration (84 per cent).
Camilia®, a teething solution from Boiron Laboratories, is an effective, safe and easy-to-use product that is focused on relieving a wide range of symptoms related to teething. From irritability, to restlessness, and painful, swollen gums, Camilia's water-based formula packaged in a pre-measured single dose offers a sensible solution for parents of infants aged one month and older.
"Camilia is a safe solution for parents looking for an effective teething medicine for their children," said Majid Djoudi, president and CEO of Boiron Canada. "With high satisfaction ratings from parents that use Camilia, it's a product that can provide relief for children's uncomfortable teething symptoms and peace of mind for parents."
On April 7, 2011, the U.S. Food and Drug Administration (FDA) warned the public about the use of over-the-counter (OTC) products containing benzocaine, an ingredient used to reduce pain in the mouth and gums. Benzocaine use may cause a rare, but serious condition where the amount of oxygen that can be carried through the blood stream is greatly reduced. This condition is called methemoglobinemia. Parents and caregivers should not use OTC benzocaine products on children under two years of age, except under the advice and supervision of a healthcare professional. For more information: fda.gov. Health Canada has issued a warning alert on this subject on April 19, 2011. For more information: hc-sc.gc.ca
Camilia does not contain benzocaine.
Almost one-third (30 per cent) of those surveyed have used homeopathic medicine to treat teething symptoms in the past, and respondents showed a strong preference for homeopathic medicines with 54 per cent of respondents indicating they would prefer to use homeopathic medicine instead of conventional medicines.
Camilia Smiles
For the second year in a row, Boiron has launched the Camilia Smiles contest, a baby photo contest that allows Canadians to share their baby's most beautiful smile. Photos can be uploaded to the contest website www.camiliasmiles.com between March 28 and June 30, 2011. All entries will be posted to the contest website, and the smile with the most votes will be awarded a $2,000 Babies "R" Us gift card. Other prizes include digital photo frames and Boiron product gift baskets.
Survey Methodology
From March 8 to March 11, 2011 an online survey was conducted among a targeted, representative sample of 1,003 Canadian parents of children aged 6 months - 5 years. All respondents are Angus Reid Forum panel members. The full dataset has been statistically weighted to ensure a representative sample. The margin of error is ±3.0%, 19 times out of 20. Discrepancies in or between totals are due to rounding.
About Boiron
The worldwide leader in homeopathy, Boiron is best known for its signature product, Oscillococcinum - Oscillo, a leading flu medicine; Camilia, Cocyntal, Coryzalia and Stodal, a line of medicines for kids; and Arnica Gel, a first aid product for muscle aches, bumps and bruises. Boiron is committed to developing homeopathic medicines by promoting scientific research and educating physicians and the public for over 75 years worldwide and 20 years in Canada.
For further information:
or to schedule an interview with a spokesperson, please contact:
BRIGITTE FILIATRAULT
Brigitte Filiatrault Relations Publiques for Boiron
514-521-8216
filiatraultb@videotron.ca